Abstract
The emergence of novel RNA viruses like SARS-CoV-2 poses a greater threat to human health. Thus, the main objective of this article is to develop a new mathematical model with a view to better understand the evolutionary behavior of such viruses inside the human body and to determine control strategies to deal with this type of threat. The developed model takes into account two modes of transmission and both classes of infected cells that are latently infected cells and actively infected cells that produce virus particles. The cure of infected cells in latent period as well as the lytic and non-lytic immune response are considered into the model. We first show that the developed model is well-posed from the biological point of view by proving the non-negativity and boundedness of model’s solutions. Our analytical results show that the dynamical behavior of the model is fully determined by two threshold parameters one for viral infection and the other for humoral immunity. The effect of antiviral treatment is also investigated. Furthermore, numerical simulations are presented in order to illustrate our analytical results.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference43 articles.
1. ICTV (2020). The species Severe acute respiratory syndromerelated coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol., 5, 536–544.
2. HWO (2021, September 21). Weekly Epidemiological Update on COVID-19, 21 September 2022. Available online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19.
3. Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports;Mahase;Br. Med. J. (BMJ),2021
4. Modeling the dynamics of COVID-19 with carrier effect and environmental contamination;Hattaf;Int. J. Model. Simul. Sci. Comput.,2021
5. Dynamics of a generalized fractional epidemic model of COVID-19 with carrier effect;Hattaf;Adv. Syst. Sci. Appl.,2022
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献